Upload File

The top documents tagged [measurable disease]

Best of ASCO Metastatic Non-Small Cell Lung Cancer
Best of ASCO Metastatic Non-Small Cell Lung Cancer
1.472 views
New Approaches in the Treatment for the Advanced Thyroid Cancer Sun Wook Kim, MD PhD Division of Endocrinology and Metabolism, Sungkyunkwan University
New Approaches in the Treatment for the Advanced Thyroid Cancer Sun Wook Kim, MD PhD Division of Endocrinology and Metabolism, Sungkyunkwan University
217 views
Results of Two Open Label Multicenter Phase II Pilot Studies (BCIRG 101 and 102) with Trastuzumab (Herceptin ® ) in Combination with Docetaxel and Platinum
Results of Two Open Label Multicenter Phase II Pilot Studies (BCIRG 101 and 102) with Trastuzumab (Herceptin ® ) in Combination with Docetaxel and Platinum
232 views
Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide (VT) for Initial Treatment of Elderly
Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide (VT) for Initial Treatment of Elderly
239 views
Disclosures for Palumbo Antonio, MD Honoraria to disclose Celgene Janssen-Cilag
Disclosures for Palumbo Antonio, MD Honoraria to disclose Celgene Janssen-Cilag
216 views
Personalised Cancer Medicine in Phase 1 Cancer Research at Rigshospitalet Ulrik Lassen MD, PH.D Phase 1 Unit
Personalised Cancer Medicine in Phase 1 Cancer Research at Rigshospitalet Ulrik Lassen MD, PH.D Phase 1 Unit
214 views
MINT study Principal Investigator: Charles E. Cox, M.D. Co Investigators: Stefan Glück, M.D
MINT study Principal Investigator: Charles E. Cox, M.D. Co Investigators: Stefan Glück, M.D
217 views
2007 UPDATE OF ASCO RECOMMENDATIONS FOR THE USE OF TUMOR MARKERS IN BREAST CANCER Clinical Practice Guideline
2007 UPDATE OF ASCO RECOMMENDATIONS FOR THE USE OF TUMOR MARKERS IN BREAST CANCER Clinical Practice Guideline
222 views
CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer PC Enzinger, BA Burtness, DR Hollis,
CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer PC Enzinger, BA Burtness, DR Hollis,
220 views
Introduction Discussion CT abdomen 3/3/06 lightheadedness and watery diarrhea. TSH was again less than 0.01, and ACTH less than 5. AST and ALT were 240
Introduction Discussion CT abdomen 3/3/06 lightheadedness and watery diarrhea. TSH was again less than 0.01, and ACTH less than 5. AST and ALT were 240
214 views
Clinicaloptions.com/oncology Expert Insight Into the First-line Treatment of Metastatic Colorectal Cancer KRAS Status in Response to Cetuximab Retrospective
Clinicaloptions.com/oncology Expert Insight Into the First-line Treatment of Metastatic Colorectal Cancer KRAS Status in Response to Cetuximab Retrospective
218 views
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects
A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects
222 views